SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-761668
Filing Date
2016-11-07
Accepted
2016-11-07 16:14:45
Documents
45
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d246773d10q.htm 10-Q 562222
2 EX-10.1 d246773dex101.htm EX-10.1 49506
3 EX-10.2 d246773dex102.htm EX-10.2 47532
4 EX-10.3 d246773dex103.htm EX-10.3 46896
5 EX-10.4 d246773dex104.htm EX-10.4 48333
6 EX-31.1 d246773dex311.htm EX-31.1 6135
7 EX-31.2 d246773dex312.htm EX-31.2 5857
8 EX-32.1 d246773dex321.htm EX-32.1 4192
  Complete submission text file 0001193125-16-761668.txt   2278649

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT drna-20160930.xml EX-101.INS 278340
10 XBRL TAXONOMY EXTENSION SCHEMA drna-20160930.xsd EX-101.SCH 25146
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drna-20160930_cal.xml EX-101.CAL 33314
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drna-20160930_def.xml EX-101.DEF 72381
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE drna-20160930_lab.xml EX-101.LAB 198680
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drna-20160930_pre.xml EX-101.PRE 134385
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36281 | Film No.: 161978275
SIC: 2834 Pharmaceutical Preparations